SCHEMBL4577253

SCHEMBL4577253

CCOC(=O)CN1CCC(Oc2ccccc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.52
PRMT6 Q96LA8 1/20 0.52
DRD2 P14416 3/20 0.49
DRD4 P21917 3/20 0.49
DRD3 P35462 3/20 0.49
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
OPRK1 P41145 1/20 0.46
KMT2A Q03164 1/20 0.46
HTR7 P34969 1/20 0.46
HRH3 Q9Y5N1 1/20 0.45
LMNA P02545 1/20 0.45
CCR8 P51685 1/20 0.45
CHRM2 P08172 1/20 0.45
CHRM3 P20309 1/20 0.45
SLC5A7 Q9GZV3 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5151941 0.89 CHRM2 (0.46) CARM1PRMT6DRD2DRD4DRD3
SCHEMBL14862739 0.87 GSK3B (0.48) KMT2AHRH3LMNA
SCHEMBL31050750 0.86 HRH3 (0.48) KMT2AHRH3
SCHEMBL11022779 0.82 KMT2A (0.56) KMT2ACHRM2CHRM3KDM4E
Hydrochloric Acid SCHEMBL4578195 0.81 CARM1 (0.55) CARM1PRMT6DRD2DRD4DRD3
SCHEMBL27622744 0.81 SLC18A3 (0.59) CARM1PRMT6DRD2DRD4DRD3
SCHEMBL9353069 0.81 BCHE (0.56) DRD2DRD4DRD3OPRK1HRH3
SCHEMBL2763577 0.80 OPRK1 (0.56) CARM1PRMT6DRD2DRD4DRD3
SCHEMBL6960252 0.80 KDM4E (0.40) KMT2AHRH3LMNAKDM4E
SCHEMBL17731135 0.79 ACSL1 (0.44) CARM1PRMT6KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435744-B2 Piperidine derivatives as NMDA receptor antagonists GEDEON RICHTER VEGYESZETI GYAR RT (HU) 2008-10-14 US disclosed
US-20040157886-A1 Piperdine derivatives as NMDA receptor antagonists UCB Biopharma SRL (BE) 2004-08-12 US disclosed
EP-1409477-A1 PIPERIDINE DERIVATIVES AS NMDA RECEPTOR ANTAGONISTS RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 2004-04-21 EP disclosed
WO-2003010159-A1 PIPERIDINE DERIVATIVES AS NMDA RECEPTOR ANTAGONISTS Richter Gedeon Vegyészeti Gyár Rt. (HU) 2003-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157886-A1 Piperdine derivatives as NMDA receptor antagonists GRIN1, GRIN2D, GRIN2C CARM1 773/4885PRMT6 1273/4885DRD2 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.